S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

MRNA Moderna Inc

37.27

-2.50 (-6.29%)

16 Nov 2024 - Closed

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Moderna Charts.

Moderna (NASDAQ:MRNA)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Moderna Charts.

Moderna Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 13 November 2024 (5 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Wednesday 13 November 2024 (6 days ago) • Edgar (US Regulatory)

Carisma Unveils Promising Pre-Clinical Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma
Friday 8 November 2024 (1 week ago) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 8 November 2024 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (2 weeks ago) • Edgar (US Regulatory)

U.S. Futures Rise as Investors Await Fed Rate Decision; Oil Prices Drop
Thursday 7 November 2024 (2 weeks ago) • IH Market News

Trump Media Shares Surge 32% Pre-Market; Tesla Jumps 13%; Coinbase Rises with BTC All-Time High
Wednesday 6 November 2024 (2 weeks ago) • IH Market News

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024
Wednesday 6 November 2024 (2 weeks ago) • PR Newswire (US)

Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)
Monday 28 October 2024 (3 weeks ago) • Business Wire

Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence
Wednesday 23 October 2024 (4 weeks ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 9 October 2024 (1 month ago) • Edgar (US Regulatory)

Shareholders of Moderna, Inc. Should Contact The Gross Law Firm Before October 8, 2024 to Discuss Your Rights - MRNA
Monday 7 October 2024 (1 month ago) • PR Newswire (US)

More Moderna Inc News Articles

Australia And New Zealan...

Gold vs US Dollar

Commonwealth Bank Of Aus...

National Australia Bank

AUD vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions